December 1, 2024
Philips' intelligent diagnostic and treatment solutions,
combined with its advanced capabilities in healthcare informatics,
uniquely position the company to drive precision imaging for a
greater number of patients
Amsterdam, the Netherlands and Chicago, USA –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today unveiled the company’s latest AI-powered
diagnostic and treatment imaging innovations to advance precise
imaging with faster, easier and more efficient workflows.
Addressing key challenges faced by radiologists, these innovations
are complemented by Philips’ industry-leading expertise in
cloud-based data management, advanced visualization, automation,
and AI. Together, they aim to reduce the administrative burden and
empower clinicians with insights to deliver better care for more
people.
“The healthcare industry is facing a perfect storm of challenges
in radiology: increasing patient volumes, skyrocketing demand for
imaging studies, and an explosion in imaging data. At the same
time, staff shortages are creating mounting pressure on already
strained resources,” said Bert van Meurs, Chief Business Leader of
Diagnosis and Treatment at Philips. “Our intelligent imaging
systems combined with our world-class informatics support
healthcare providers in embracing innovative solutions that enhance
efficiency, reduce the administrative burden, and empower
radiologists to focus on delivering precise, high-quality
care.”
The Philips Future Health Index 2024 Report shows 99% of
radiology leaders surveyed struggle with staff shortages, with
nearly 4 in 5 facing financial pressures, and 45% experiencing
symptoms of burnout. Radiologists are also seeing a 40% increase in
patients with complex diseases [1] in clinical areas like
cardiology and neurology, which is driving the need for imaging
exams and a 60% increase in imaging data [2]. At this year’s RSNA,
Philips will demonstrate how it is uniquely positioned to help
mitigate these challenges with breakthrough innovations that
advance precision imaging for more patients and enhance
productivity through seamless integration of imaging and
informatics.
Leadership in innovative helium-free MRI
operations Philips will unveil the industry’s first and
only wide-bore, high-performance helium-free [3] MR scanner with
fully integrated cloud-based, AI-driven, automated quantitative
reporting capabilities [4] for specific disease areas like
neurology and oncology. With AI assistance at every step of the
workflow, from planning to imaging and reporting, Philips’ next
generation BlueSeal 1.5T MRI boosts productivity, ease of use and
access to precision diagnosis around the world, while caring for
the planet. Philips’ revolutionary BlueSeal technology sets new
standards in MRI as the lightest 70 cm system available today [5],
making it easier to install and cost-effective to maintain,
enabling flexible installations and wider access in new
locations.
Breakthrough innovations in Diagnosis and
TreatmentMaking its debut in North America at RSNA is the
fully AI-enabled CT 5300, featuring Precise Image AI-based
reconstruction software to assist at every step of the CT workflow,
while reducing radiation dose and improving image quality for
complex exams like cardiac imaging. Philips will also spotlight
Spectral CT 7500, providing spectral CT solutions across a wide
range of clinical areas including cardiology, oncology, neurology,
musculoskeletal, and pediatrics. With more than 24 million
spectral exams performed to date, Spectral CT 7500 has been shown
to deliver up to 97% diagnostic sensitivity compared to 55% with
conventional CT [6]; 96% certainty of cyst vs. lesion compared to
30% with conventional CT [7]; and a 26% reduction in follow-up
scans due to incomplete diagnosis [8].
Philips is elevating image quality in ultrasound with the newest
releases of its EPIQ Elite and Affiniti systems featuring new
workflow and quantification automation to make exams faster and
reproducible to help increase clinical confidence. With more than
100 optimized presets across multiple clinical applications,
Philips’ latest innovations in ultrasound help reduce exam times
and variability. This is meant to increase efficiency with over 50%
reduction in time for image optimization during abdominal and
obstetrics exams [9]. Also showcased will be the latest
Azurion 7 platform to support image-guided interventional
procedures with a 17% reduction in procedure time and a 12%
reduction in patient preparation time, bringing the ability to
treat one more patient per day [10].
Expanded strategic collaboration with AWSAt
RSNA Philips will showcase its advanced Healthcare Informatics
capabilities for data management, advanced visualization,
automation, and AI to help reduce administrative burdens and
empower clinicians with insights to deliver better care. In the
run-up to the event, Philips expanded its strategic collaboration
with Amazon Web Services (AWS) to offer Philips’ integrated
diagnostics portfolio in the cloud, including radiology, digital
pathology, cardiology [11], and AI advanced visualization [11]
solutions. As part of the agreement, Philips aims to create robust
and scalable generative AI applications that leverage
state-of-the-art foundation models from Amazon Bedrock, and
seamlessly integrate into clinical workflows.
Philips will also debut the latest 510(k) clearance of its
Radiology Operations Command Center remote scanning and remote
protocol management features [12] enabling real-time collaboration
between imaging experts and on-site technologists, virtually
anywhere, to help streamline radiology operations and workflows to
provide high-quality imaging to more patients at lower costs.
Paired with the world’s first and only helium-free mobile MRI
solution, Philips continues to expand quality care to large
populations of traditionally underserved patients in a more
accessible and sustainable way.
Visit Philips at RSNA for more information.
[1] 3 Key market trends source: The Burden of Chronic Disease
(Karen Hacker); The healthcare data explosion (RBC Capital
Markets); Radiologist burnout (Catalina imaging)[2] 3 Key market
trends source: The Burden of Chronic Disease (Karen Hacker); The
healthcare data explosion (RBC Capital Markets); Radiologist
burnout (Catalina imaging)[3] Helium-free operations. 7 liters of
helium is permanently enclosed in the cryogenic circuit.[4]
BlueSeal XE/SE and Smart Reading are not yet CE marked, not cleared
in all countries, and not yet available for delivery in any
country. Please consult your Philips contact person for further
information. [5] Compared to conventional 1.5T zero boil off
systems in the industry BlueSeal MR system weight (with cryogen)
2,300 kg (5,071 lbs). [6] Mellander, et al. (Skåne University
Hospital, Lund, Sweden), Acta Radiology (2022) DOI:
10.1177/02841851221130612[7] Andersen MB, Ebbesen D, Thygesen J,
Kruis M, Rasmussen F. Impact of spectral body imaging in patients
suspected for occult cancer: a prospective study of 503 patients.
Eur Radiol. 2020 Oct;30(10):5539-5550. doi:
10.1007/s00330-020-06878-7[8] Follow-up Recommendation Rates
Associated with Spectral Detector Dual-Energy CT of the Abdomen and
Pelvis: A Retrospective Comparison to Single-Energy CT. Atwi, Noah
E. et al. J Am Coll Radiol. 2020;17:940-950[9] D001833994,
Marketing Claim Evidence for VM12.0 Workflow Efficiency Quick
Launch Preset[10] Results from study conducted at St. Antonius
Hospital. Results verified by NAMSA, independent third-party expert
on study design and analytics. Results are specific to the
institution where they were obtained and may not reflect the
results achievable at other institutions.[11] Available on cloud in
2025.[11] Available on cloud in 2025.[12] Remote editing and
protocol management are functionalities powered by the 510(k)
cleared ROCC Console solution. ROCC Console is not to be used
without a trained and qualified user at the scanner.
For further information, please contact:
Kathy O’ReillyPhilips Global External RelationsTel.: +1
978-221-8919E-mail : kathy.oreilly@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being through meaningful innovation. Philips’ patient- and
people-centric innovation leverages advanced technology and deep
clinical and consumer insights to deliver personal health solutions
for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, ultrasound, image-guided therapy, monitoring
and enterprise informatics, as well as in personal health. Philips
generated 2023 sales of EUR 18.2 billion and employs approximately
69,300 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
- philips-next-gen-blueseal-mri-2
- ct-5300-product-image-2
- next-gen-blueseal-mri-with-smart-reading
Koninklijke Philips NV (NYSE:PHG)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Koninklijke Philips NV (NYSE:PHG)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
